Showing results (181-190 of 1,320) with videos related to

Sort By:
Pageof 132
Journal of the National Cancer Institute|October 23, 1997
Cross-reactivity of C219 anti-p170(mdr-1) antibody with p185(c-erbB2) in breast cancer cells: cautions on evaluating p170(mdr-1)B Liu, D Sun, W Xia, et al.
Oncogene|July 6, 2001
p27 Kip1 inhibits HER2/neu-mediated cell growth and tumorigenesisH Y Yang, R Shao, M C Hung, et al.
Cancer Research|April 20, 2001
E1A sensitizes HER2/neu-overexpressing Ewing's sarcoma cells to topoisomerase II-targeting anticancer drugsZ Zhou, S F Jia, M C Hung, et al.
The British Journal of Nutrition|August 15, 2001
Learning behaviour and cerebral protein kinase C, antioxidant status, lipid composition in senescence-accelerated mouse: influence of a phosphatidylcholine-vitamin B12 dietM C Hung, K Shibasaki, R Yoshida, et al.
Seminars in Oncology|January 5, 2002
Targeting HER2: recent developments and future directions for breast cancer patientsS C Wang, L Zhang, G N Hortobagyi, et al.
Cancer Research|September 1, 1995
Suppressed transformation and induced differentiation of HER-2/neu-overexpressing breast cancer cells by emodinL Zhang, C J Chang, S S Bacus, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 14, 1995
Cell cycle-dependent regulation of p185neu: a relationship between disruption of this regulation and transformationN Kiyokawa, D H Yan, M E Brown, et al.
Cancer Research|October 1, 1988
Expression of an altered epidermal growth factor receptor by human glioblastoma cellsP A Steck, P Lee, M C Hung, et al.
Life Sciences|September 4, 2001
Cerebral protein kinase C and its mRNA level in apolipoprotein E-deficient miceM C Hung, K Hayase, R Yoshida, et al.
Oncogene|January 1, 1990
Effect of glucocorticoids on oncogene transformed NIH3T3 cellsA Matin, K L Cheng, T C Suen, et al.
Pageof 132